Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amneal Pharmaceuticals Inc. (AMRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,597,808
  • Shares Outstanding, K 73,870
  • Annual Sales, $ 775,790 K
  • Annual Income, $ -469,290 K
  • 36-Month Beta 1.28
  • Price/Sales 2.06
  • Price/Cash Flow 10.37
  • Price/Book 1.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.28
  • Number of Estimates 8
  • High Estimate 0.31
  • Low Estimate 0.25
  • Prior Year 0.23
  • Growth Rate Est. (year over year) +21.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.09 +18.96%
on 08/09/18
22.41 -3.97%
on 08/15/18
+2.83 (+15.14%)
since 07/17/18
3-Month
15.77 +36.46%
on 06/28/18
22.41 -3.97%
on 08/15/18
+4.71 (+28.02%)
since 05/17/18
52-Week
13.47 +59.76%
on 05/09/18
25.70 -16.26%
on 09/21/17
+3.57 (+19.89%)
since 08/17/17

Most Recent Stories

More News
Amneal Pharmaceuticals (AMRX) Jumps: Stock Rises 5.6%

Amneal Pharmaceuticals (AMRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

ENDP : 15.64 (-1.94%)
AMRX : 21.52 (-0.51%)
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings Estimates

Amneal (AMRX) delivered earnings and revenue surprises of 4.35% and -0.28%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

AMRX : 21.52 (-0.51%)
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that a panel of three Circuit Judges of the U.S. Court of Appeals for the Federal Circuit has affirmed the March 30, 2017 ruling of Judge Richard...

IPXL : 18.30 (unch)
AMRX : 21.52 (-0.51%)
Impax Laboratories, LLC Announces Results of Tender Offer for 2.00% Convertible Senior Notes Due 2022

Impax Laboratories, LLC ("Impax" or the "Company"), a wholly-owned subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX), announced today the final results of its previously announced cash tender offer...

IPXL : 18.30 (unch)
AMRX : 21.52 (-0.51%)
Amneal and Impax Complete Business Combination

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. ("Impax") today announced that they have completed their business combination to form Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"). As...

IPXL : 18.30 (unch)
AMRX : 21.52 (-0.51%)
Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600

Apergy Corp. (NYSE: APY) will replace 3D Systems Corp. (NYSE: DDD) in the S&P MidCap 400, and 3D Systems will replace Impax Laboratories Inc. (NASD: IPXL) in the S&P SmallCap 600 effective prior to the...

DDD : 19.04 (-0.94%)
IPXL : 18.30 (unch)
SPGI : 203.11 (+0.21%)
APY : 43.15 (-0.48%)
DOV : 83.95 (+1.22%)
AMRX : 21.52 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AMRX with:

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

2nd Resistance Point 21.96
1st Resistance Point 21.74
Last Price 21.52
1st Support Level 21.28
2nd Support Level 21.03

See More

52-Week High 25.70
Last Price 21.52
Fibonacci 61.8% 21.03
Fibonacci 50% 19.59
Fibonacci 38.2% 18.14
52-Week Low 13.47

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar